Biosocieties

Papers
(The median citation count of Biosocieties is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Between technology transfer and South–South collaboration: an Indo-Cuban experiment in biopharmaceutical innovation20
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria17
Making pain social: developing a critical social science of pain17
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests16
Horizoning work in a (de-)contaminated village in Fukushima: how are these Japanese urbanites living a normal life there?10
When sociality fails to produce solidarity: environmental NGOs and the politics of public engagement in contemporary China9
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation6
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time5
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies5
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence5
Making sense of snakebite: the place of biological toxins in social scientific analyses of toxicity5
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis5
Data roles: youth mental health outcome measures and the young people who defy them4
Post-identifiability in changing sociotechnological genomic data environments4
Choreographies of nearness: self and other in personal cancer immune therapy research4
Our thanks to founding editor Professor Nikolas Rose3
Negotiating the necessity of biomedical animal use through relations with vulnerability3
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar3
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices3
Sanitizing psychedelics: the biopolitics of non-hallucinogenic psychoplastogens3
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building3
Epistemology of the side effect: anecdote and evidence in the digital age3
Making death through producing life: Necrovalue and the political economy of death3
Turning biodiversity data into evidence: the role of protocols in the epistemology of evidence-based conservation3
Psychedelic innovations and the crisis of psychopharmacology3
Introduction to the special issue: The Near Human in life science, biomedicine, and care3
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities3
Challenges in public policy for the implementation of pharmacogenetic tests in Europe3
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–20202
Navigating biosafety concerns within COVID-19 do-it-yourself (DIY) science: an ethnographic and interview study2
Population anxieties in constituting Nordic welfare state futures: affective biopolitics in the age of environmental crises2
Good donors, bad donors and oddities in the family tree: genomics, donation and reproductive citizenship in Finnish egg donor accounts2
Allostatic load: historical origins, promises and costs of a recent biosocial approach2
“Is your brain in danger of overheating?”: neurobiologizing the labouring subject in cognitive capitalism2
Microbial eccentricity: more-than-human creativity in anthropoeccentric worlds2
Afterword: the politics of suspension as an analytical gestalt switch2
Foetal programming meets human capital: biological plasticity, development, and the limits to the economization of life2
Correction: Reproducing the normal and the pathological in personalized cancer medicine clinical trials2
‘Nonetheless biosocial’: experiences and embodied knowledge of birth cohort participants in the UK and Brazil1
Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria1
On psychedelic liberalism and mad trust: towards varieties of willing in extreme experiences1
In whose pockets? How small Danish patient organisations balance legitimacy, representation and dependency in collaboration with public sector medical researchers and the life science industry1
Reproducing the normal and the pathological in personalized cancer medicine clinical trials1
Anticipating and suspending: the chronopolitics of cryopreservation1
Formatting patient knowledge and channelling participation: how patient organisations work under authoritarianism1
Antibiotics in the environment: molecularisation, drug resistance and pharmaceutical pollution in India1
Chronic pain across clinical settings: the changing understanding of pain and its treatment in endometriosis1
The effects of COVID-19 on imagined reproductive futures1
‘Our biology is listening’: biomarkers as molecular vestiges of early life and the production of positive childhood experiences in behavioral epigenetics1
The normal is pathological: semi-conscious brains, mindless habits, and the paradoxical science of mindfulness1
Introduction to Special Issue: Reconceptualising toxicity and environmental justice1
Inscrutable futures: biotechnology, architecture, and planetary ecology in late industrial China1
Profit and power: negotiating medical authority and an informed consumer-patient in transgender surgery1
Correction: Core values of genomic citizen science: results from a qualitative interview study1
Guardians of ableist family formation: the legitimation work of Danish abortion committees in cases of termination for fetal anomaly1
Forged in fires: notes on adaptive intelligence among Roma children in the "Terra dei Fuochi"1
0.025837898254395